ABCC4 and colorectal carcinoma: Polymorphism rs3742106 in the 3’-UTR region of ABCC4 mRNA determines the sensitivity of CRC patients to 5-FU/capecitabine-based chemotherapy, individuals with the T/T genotype being more sensitive than those with G/G and G/T genotypes [64].